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A role for NK cells in hematopoietic homeostasis was originally suggested by Cud-
kowicz and co-workers (1, 2), who observed that NK cells are the major effector cells
of hybrid resistance to parental bone marrow transplants in irradiated mice. NK
cells differentiate in the bone marrow (3), from where they migrate at an early stage
of differentiation so that mature NK cells are rare in normal bone marrow (4) . How-
ever, during experimental virus infection in mice, activated NK cells that suppress
hematopoiesis can be demonstrated (5). NK cell depletion in vivo in mice using
mAbs results in increased numbers of myeloid precursor cells in the spleen, sug-
gesting that in physiological conditions NK cells serve as regulators of extramedul-
lary myelopoiesis (6) . Several lines ofevidence in human and experimental pathology
suggest a role for NK cells in suppression of hematopoiesis (for a review see refer-
ence 7) .
Human NK cells have been shown to suppress the growth of hematopoietic colo-
nies in vitro (8-10). All or most of this suppressor activity is mediated through re-
lease of a soluble factor that we identified as TNF (9, 11). TNF is produced by NK
cellsupon contact with their target cells or with precursor cell-enriched bone marrow
cell preparations (11) ; it cooperates with IFN--y, another product of NK and T cells
(12), in suppressing hematopoietic colony formation (11, 13). However, in some cases,
NK cells stimulate colony formation by releasing CSF (14-17); thus, the effect of
NK cells on hematopoiesis, like that of T cells, may be complex .
Productionofa large number of factors has been attributed to NK cells. NK cells
have been shown to produce burst-promoting activity (BPA)' (14, 15, 18). Several
factors mediate such activity, and the possibility that NK cells produce IL-3 and
granulocyte/macrophage CSF (GM-CSF), the two lymphokines with known BPA
activity, has not been tested directly. Several types of CSF activity that sustain the
growth ofGM colonies (16), enhance GM colony formation from human peripheral
blood (17), or induce growth of megakaryocytes (19) have been detected in superna-
tants from mitogen-stimulated large granular lymphocytes (LGL) or from cell prepa-
rations enriched for NK cells. Large quantities of IL-1 (hemopoietin-1), a cytokine
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synergizing with various CSF to induce growth of early precursor cells of several
lineages, have also been suggested to be produced by NK cells (20, 21). However,
in many of these reports, the factor mediating the activity produced was not identified
and/or NK cells were not positively demonstrated to be the activity-producer cells,
and no CSF activity has been detected by Hermann et al. (10) in supernatant fluids
from NK cell clones.
We recently developed a method by which very large numbers of NK cells, >99%
pure, can be obtained from cocultures of PBMC with irradiated lymphoblastoid
cells (22). Using these cell preparations, we demonstrated that NK cells can be in-
duced to transcribe IFN--y and TNF genes upon specific stimulation with rIL-2 in
combination with ligands for the NK cell receptor for IgG-Fc (FcR), CD16 antigen,
or upon nonspecific stimulation with phorbol-diester and calcium ionophore (23).
These advances in the methodologies to purify and study NK cells and the avail-
ability of cDNA probes for all the major CSF types allowed us to analyze in detail
CSF production by NK cells.
In this paper, we demonstrate that activated NK cells produce large amounts of
GM-CSF; IL-3 and CSF1 transcripts were demonstrable in NK cells under certain
conditions of stimulation . No evidence of G-CSF, IL-la, or IL-1/3 transcripts was
found in any NK cell preparation, independent of the stimulus used .
Materials and Methods
Cell Lines.
￿
The human B-lymphoblastoid RPMI 8866 (22) and bladder carcinoma 5637
(21, 24) cell lines, and the murine mAb-producing hybrid cell clones were maintained in cul-
ture in RPMI 1640 (Flow Laboratories, Rockville, MD) supplemented with 10% FCS (Flow
Laboratories). All cell lines were free of mycoplasma contamination on repeated testing.
Monoclonal and PolyclonalAntibodies.
￿
mAbs B73.1 (IgGI, anti-CD16) (4), B36.1 (IgG2b, anti-
CD5) (25), B52.1 (IgM, anti-CD14 on monocytes), and B13 .4 (IgM, anti-monocyte granulo-
cyte) (25, 26) were produced and characterized in our laboratory. 3G8 (IgGl, anti-CD16)
(27) was produced from cells kindly provided by Dr. J. Unkeless (Mount Sinai Medical School,
New York, NY); N901 (IgGl, anti-NKH-1 antigen) (28) was kindly provided by Dr. J . Griffin
(Dana Farber Cancer Institute, Boston, MA). OKT3 (IgG2a, anti-CD3) was produced from
cells obtained from the American Type Culture Collection (Rockville, MD). The anti-IFN-y
B133 .1 and B133 .5 and the antiTNF B154.7 and B154.9 antibodies used for the IFN-T and
TNF RIA were produced and characterized in our laboratory (12, 29). Antibody B133.3 (IgGI)
was used to inactivate the biological activity of IFN-y (1 ml of ascites fluid neutralizes >10'
U of rIFN-'y). mAbs to GM-CSF were obtained from Olympus Co. (Media, PA) and, after
labeling with biotin, were used for immunoprecipitation. A polyclonal sheep antiserum to
human rGM-CSF (30) (neutralizing titer >6,000 U/ml) and a rabbit polyclonal antiserum
to rIL-3 (31) were used in inactivation experiments. When indicated, purified antibodies were
labeled with biotin or linked to CNBr-Sepharose 4B (Pharmacia Fine Chemicals, Uppsala,
Sweden) according to routine procedures. The polyclonal FITC-goat F(aU)2 anti-mouse Ig
and the rabbit IgG anti-bovine erythrocytes (E) were purchased from Cooperbiomedical (Mal-
vern, PA). The goat F(ab')2 anti-mouse IgG used to prepare the E for indirect rosetting was
produced in our laboratory, absorbed on human IgG and affinity-purified on a mouse IgG-
Sepharose 4B column (Pharmacia Fine Chemicals).
Peripheral BloodLymphocytes, NK Cells and TCells.
￿
Peripheral blood was obtained by venipunc-
ture from adult healthy donors using heparin as anticoagulant. PBMC were separated on
Ficoll-Hypaque density gradient (Lymphoprep, Nyegaard and Co., Oslo, Norway). PBL were
prepared from PBMC depleted ofmonocytes aftertwo cycles ofadherence on plastic surfaces
(45 min, 37°C) and depletion of B52.1/BI3 .4' monocytes and mature myeloid cells by in-
direct antiglobulin rosetting (4). Fresh NK and T cells were prepared by negative selection
using the indirect rosetting method as described (32). To obtain large numbers of NK cells,CUTURI ET AL .
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short-term bulk cultures of these cells were prepared as previously described in detail (22,
33) . Briefly, PBMC were cultured at 37'C with 50-Gy irradiated RPMI 88661ymphoblastoid
cells for 10 d (5 :1 PBMC/B lymphoblastoid cells, 2.5 x 10 5 PBMC/ml RPMI/100 /0 FCS)
in tissue culture plates in a 5% C02 humidified atmosphere . The total number of cells re-
covered after a 10-d culture is increased, on average, 10-fold, and the cell population com-
prises 60-80% CD16'/NKH-1'/CD3 - NK and 20-40% CD3'/CD16-/NKH-1- T cells .
Homogeneous populations ofNK andT cells were negatively selected and purified by den-
sity gradient centrifugation after sensitization of thelymphocytes with amixtureofantimono-
cyte B52 .1 and B13.4, and either anti-CD3 and anti-CD5, or anti-CD16 and anti-NKH-1
antibodies, respectively, and indirect rosetting with CrC13-treated goat anti-mouse Ig-coated
E (4) . Both the NK and the T cells purified from these cultures have morphologic, pheno-
typic, genotypic, and functional properties identical to those of the two subsets freshly ob-
tained from PBL (22, 33, and data not shown) . However, unlike fresh cells, the majority
of these cells express HLA-DR antigens . Monocytes and B cells were not detected in the
cultures on day 10 (22) . Thepurity ofthe variouslymphocyte preparations (on average>98%)
was always determined by indirect immunofluorescence (flow cytofluorometry) performed
as described (4) using a panel of mAbs .
Lymphocyte Stimulation .
￿
The purified fresh PBL, and the NK and T cell subpopulations
obtained from the bulk cultures, were cultured (37°C, 5 x 10 6 cells/ml RPMI/10% FCS)
for the indicated periodsoftime with different inducers . FcR(CD16) ligandswere anti-CD16
antibody (3G8) linked to CNBr-Sepharose 4B (5 mg antibody/ml Sepharose, 5A .1 beads/106
cells) and particulate immune complexes, i.e ., IgG-sensitized bovine E (EA7S) prepared as
previously described (34) . Sepharose-linked irrelevant antibodies (anti-CD3 OKT3, anti-HLA
class I W6.32) andEwere used as controls . When indicated, purified humanrIL-2 was present
(100 U/ml) (rIL-2, 5 x 106 U/mg in a standard CTLL assay ; Takeda Chemical Industry,
Inc., Osaka, kindly provided by Dr . T . Taguchi, Osaka University, OsakaJapan) . Alterna-
tively, lymphocytes were stimulated with phorbol dibutyrate (PDBu; Peter Borchert, Eden
Prairie, MN), 2.5 x 10' M, and the Cat' ionophore A23187 (0.2 Wg/ml ; Sigma Chemical
Co., St . Louis, MO). After culture, the cell-free supernatant fluids and/or cells were collected,
Sepharose beads were detached from the cells by vigorous vortexing, and they were elimi-
nated from the cell suspension after a 1-min centrifugation at 500 rpm. Particulate immune
complexeswere removed by lysis with hypotonic medium . Ligand-free cells were washed and
used for different assays. Cell viability was >95% in all conditions and recovery was -800 /o
of the original input without loss of lymphocyte subsets .
IFN-y and TNF RIA .
￿
These were performed as previously described in detail (29, 35)
on cell-free supernatants obtained from the cells induced as above. Purified human natural
IFN--y (Interferon Sciences, New Brunswick, NJ) and purified human rTNF (5 x 107 U/mg
on L929 cells, kindly provided by Dr. H. M. Shepard, Genentech Inc., South San Francisco,
CA) were used in each assay to constructthe standard curve . Sensitivity oftheRIA for IFN-1'
and forTNF was 0.2 U/ml and 0.1-0 .2 U/ml, respectively.
Northern Blot Hybridization .
￿
Northern blots were performed as previously described in de-
tail (29) . Briefly, total cytoplasmic RNAs were extracted from uninduced and induced cells .
Equal amounts ofRNA (20 Rg/lane, as quantified by spectrophotometric reading at 260 and
280 nm) were size fractionated in a 1% agarose-formaldehyde gel . When indicated, RNA
was poly(A) selected and the amount of poly(A)' RNA derived from 200 t4g of totalRNA
was loaded per lane . Ethidium bromide-stained gels were visualized to assess integrity of
RNA and to verify that equal amounts of total RNA were loaded in each lane. RNA was
transferred by capillarity to nitrocellulose paper. ThecDNA probes used formRNA detec-
tion, all isolated at theGenetics Institute, were : humanGM-CSF probepCSF1 (36), human
CSF1 probe p3A CSF69 (37) ; human IFN--y probe pSWIF; human G-CSF probe; gibbon
IL-3 probe pCSFMLA, hybridizing withhumanIL-3 mRNA (30) ; humanIL-la and IL-1R
probes . The humanTNFcDNA probe was kindly provided by Dr. H .M. Shepard (Gen-
entech Co .) The phosphoglycerate kinase (PGK) cDNA probe (38), detecting an mRNA
constitutively expressed in lymphocytes, was obtained through the American Type Tissue
Collection and used as control . Probes were excised from their vectors, purified by gel elec-
trophoresis, labeled with hexanucleotide primers and [12P]dCTP, and used for hybridiza-
tion . After hybridization and washing, the filters were autoradiographed usingXAR film572
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(Eastman Kodak Co., Rochester, NY) and an intensifying screen (DuPont Co., Wilmington,
DE).
GM-CSFImmune Prec:~itation.
￿
Purified NK cells were cultured (16 h, 37°C) in methionine-
free RPMI 1640 medium (Flow Laboratories) supplemented with 5% dialyzed FCS and
[3sS]methionine (100 ,uCi/ml, 5 x 106 cells/ml; sp act 1,245 Ci/mMol, Amersham Interna-
tional, Arlington Heights, IL) with or without added PDBu (2.5 x 10- 'M) and A23187 (0.2
Fig/ml). The cell-free supernatant was collected and precleared with streptavidin-Agarose beads
(Bethesda Research Life Technologies, Inc., Gaithersburg, MD), 25 ttl/ml supernatant, 2 h
at 4°C). 2-ml aliquots of supernatants were then incubated with anti-GM-CSF mAb or an
irrelevant isotype-matched antibody used as control (15 14g). Both antibodies were biotin la-
beled according to standard procedures. After a 2-h incubation at 4'C, 15 141 ofstreptavidin-
agarose beadswere added, and the incubation was continued for 2 h. The beads were washed
six times with 0.15 M NaCl containing 4 mM EDTA, 0.2 mM PMSF, 0.05% NaN:31 10 mm
Hepes, 0.1 Tween-20, resuspended in acrylamide sample buffer with added DTT (4 mM;
Sigma Chemical Co.) as a reducing agent, and boiled for 10 min. The samples and the '4C-
labeled molecularweight standards (Amersham International) were electrophoresed on a 12.5170
polyacrylamide-SDS gel (SDS-PAGE). After drying, the gels were exposed to a Kodak XAR
film with intensifying screen for 5 d.
CellLines andChronicMyeloidLeukemia (CML)BlastProliferation.
￿
The humanT cell leukemia
line TALL-101 was kindly provided by Dr. G. Rovera (Wistar Institute). TALL-101 requires
GM-CSF for growth and was maintained in medium supplemented with 5 ng/ml rGM-CSF.
rCSF, in pure form or in the supernatant fluid of transfected COS cells, were produced at
the Genetics Institute. TALL-101 growth is not supported by G-CSF and only minimally
by IL-3, but both lymphokines synergize in inducing TALL-101 growth (39). Proliferation
was determined in short-term cultures measuring [3H]TdR incorporation in TALL-101 cells
seeded at 104/well in 96-well round-bottomed microtiter plates (Falcon Labware, Oxnard,
CA) in the presence ofthe indicated concentrations of recombinant cytokines or conditioned
media from NK and T cells. After a 5-d incubation at 37°C, 2 ACi of [3H]TdR (Amersham
International) was added to each well and the cells were harvested 18 h later onto fiberglass
filters using an automated harvester (Skatron, Inc., Sterling, VA). Isotope incorporation was
measured with a liquid scintillation counter. All data are presented as mean cpm from tripli-
cate cultures.
The CML assay was performed according to previously described procedures (40). Briefly,
frozen primary CML blast cells were thawed and cultured overnight. Viable mononuclear
cells were purified by centrifugation through a Ficoll-Hypaque gradient and seeded at 2 x
104/well in microtiter wells in the presence of the indicated concentrations of recombinant
cytokines or conditioned media. Proliferation was measured by ['H]TdR incorporation after
a 72-h culture, as described above for TALL-101 cells. The assay is sensitive to GM-CSF,
IL-3, and IFN-y (30, 31, 40).
Results
Accumulation of mRNA for CSF in Human NK Cells.
￿
Total cytoplasmic RNA was
extracted from NK cells purified from the 10-d cultures of PBMC with irradiated
B-lymphoblastoid cell lines and incubated for 2 h in medium alone or supplemented
with 100 U/ml rIL-2, CD16 FcR ligands (Sepharose-linked 3G8 antibody or EA7S),
rIL-2 and CD16 ligands, or PDBu (2.5 x 10-IM) and A23187 (0.2 Ag/ml). Northern
blots were hybridized with cDNA probes for the various cytokines. NK cells cul-
tured in medium did not constitutively express transcripts for any of the cytokines
tested. Accumulation ofmRNA for GM-CSF (Fig. 1) was detected in NK cells stimu-
lated with IL-2 and 3G8-Sepharose. The two stimuli together acted synergistically
in inducing mRNA accumulation but significantly greater accumulation was ob-
served upon stimulation with PDBu and A23187 (Fig. 1). Stimulation with immune
complexes (EA7S) gave results equivalent to thoseobtained with 3G8-Sepharose (notCUTURI ET AL .
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FIGURE 1 .
￿
Accumulation of GM-CSF, CSF-1, and IL-3 mRNA
in humanNK cells stimulated with 100 U/ml HL-2, 3G8-Sepha-
rose, rIL-2 and 3G8-Sepharose, or 2.5 x 10-7M PDBu and 0.2
kg/ml A23187 . Total cytoplasmic RNA was extracted from NK
cells (CD3/CD5- cells from 10-d cultures ofPBMC with irradi-
ated RPMI 8866 cellsand incubated [2 h, 37 °C] in the presence
of various inducers) . After electrophoresisand transfer to nitrocel-
lulose, RNAwas hybridized to the indicatedcDNA probes. Amount
and integrity ofRNAwaschecked by ethidium bromide staining .
This experiment is representative ofat least four experiments per-
formed for each cytokine, with identical results .
shown) . Accumulation of mRNA for CSF1 was observed in NK cells stimulated
with HL-2 and 3G8-Sepharose, butnot in NK cells stimulated with either stimulus
alone or in those stimulated with PDBu and A23187 (Fig. 1) . On the contrary, IL-3
transcripts were detected in NK cells only when they were stimulated with PDBu
and A23187 . Transcripts for G-CSF, IL-la, or IL-1/3 were neverdetected in anyNK
cell preparations under the conditions tested .
To confirm that the GM-CSF transcripts detected were from NK cells and not
from possible contaminantTcells, mRNA was isolated from NK andTcells purified
from 10-d PBMC cultures and stimulated with CD16 ligands (3G8-Sepharose) as
an NK-specific stimulus, and with CD3 ligands (OKT3-Sepharose) as a T -specific
stimulus (Fig. 2) . HL-2 induced accumulation ofGM-CSF transcripts in both NK
andT cells; 3G8-Sepharose induced accumulation ofGM-CSF transcripts by itself
or in synergy with HL-2, only in NK cells, and OKT3-Sepharose only in T cells .
Stimulation withW6.32-Sepharosewas ineffectiveboth onNK andTcells (not shown) .
Upon comparable stimulation, the accumulation ofGM-CSF mRNA observed in
NK cells was always higher than that observed in theT cells from the same donors .
To confirm that NK cells, under the stimulation conditions used, do not tran-
scribe G-CSF, IL-la, and IL-1/3 genes, poly(A)' RNA was isolated from cultured
NK cells either unstimulated or stimulated with 3G8-Sepharose/rIL-2 or with
PDBu/A23187, andwas analyzed by Northern blotting . TotalcytoplasmicRNA from
the 5637 cell line (21, 24) was used as positive control . As expected, stimulation with
3G8 Sepharose/rIL-2 induced accumulation ofGM-CSF transcripts inNK cells and
PDBu/A23187 induced it both in NK and in T cells (Fig . 3) . GM-CSF transcripts
are present in low abundance in 5637 cells (24) and were detectable after a longer
exposure time than that used in Fig . 3 (not shown) . IL-3 transcripts were detectable
inNK and T cells when stimulated with PDBu/A23187 . G-CSF, IL-la, and IL-1(3
transcripts were not detected in either NK or T cell poly(A)' RNA . The efficiency574
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FIGURE 2 .
￿
Effect ofCD161igands andCD3 ligands, in syn-
ergy with rIL-2, onGM-CSFmRNA accumulation inNK
andT cells . Total cytoplasmic RNAwas extracted fromNK
andT cells, purified as described in MaterialsandMethods,
and stimulated with 100U/ml rIL-2, 3G8-Sepharose, 3G8-
Sepharoseand rIL-2, OKT3-Sepharose, or OKT3-Sepha-
rose and rIL-2 . After electrophoresis and transfer to nitrocel-
lulose, RNA was sequentially hybridized to the GM-CSF
cDNA probe and as a control for amount and integrity of
RNA, to the PGK cDNA probe, after stripping the first
probe.
FIGURE 3 .
￿
Northern blot analysis of the presence ofcytokine gene tran-
scripts in poly(A)' RNA from NK andT cells . Total cytoplasmic RNA
was isolated from cultured T cells stimulated for 2 hwith PDBu/A23187
or from cultured NK cells stimulated for 2 h with 3G8-Sepharose/rIL-2
or PDBu/A23187 . Poly(A)' RNA, purified from 200,ug of total RNA,
or 20 pg total cytoplasmic RNA from the cell line 5637, were loaded in
each lane as indicated .CUTURI ET AL .
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of the hybridization ofthese probes was demonstrated by the positive signal obtained
with total RNA from 5637 cells (Fig . 3) .
Kinetics of Cytokine Transcript Accumulation in FreshandCulturedNK -Cells.
￿
Total cyto-
plasmic RNA was isolated from cultured NK cells stimulated for different times with
3G8-Sepharose/rIL-2 . Accumulation of IFN-y, TNF, GM-CSF, and CSF1 tran-
scripts was analyzed by Northern blot (Fig. 4 A) . As previously reported (23), IFN-'Y
and TNFmRNA accumulation peaked at 1 h after stimulation . The peaks of both
GM-CSF and CSF-1 accumulation were at 2-4 h . Kinetics of expression of TNF
and GM-CSF genes were different in fresh (Fig . 4 B) compared with cultured NK
cells. Because of the difficulty in obtaining large numbers of fresh NK cells, only
RNA from cells stimulated for 2 or 18 h with 3G8-Sepharose/rIL-2 or for 2 h with
PDBu/A23187 was analyzed . TNF mRNA accumulation in fresh NK cells at 2 h
was higher than at 18 h, whereas the reverse was observed for GM-CSF mRNA ac-
cumulation .
Immunoprecipitation ofGM-CSFfrom NK Cell Supernatant Fluid.
￿
Purified (10-d cul-
ture) NK cells from two donors were cultured for 18 h in the presence of [3sS]me-
thionine in culture medium with or without PDBu/A23187 . Supernatant fluids were
collected and precipitated with biotin-labeled mAbs to human GM-CSF and
streptavidin-agarose . The precipitate was analyzed by SDS-PAGE (Fig . 5) . No specific
precipitates were obtained from the supernatant fluids of unstimulated NK cells,
whereas a major protein of 23 x 103 apparent molecular weight, corresponding to
that expected ofhuman GM-CSF, was precipitated from the supernatant fluids of
both NK cell preparations stimulated with PDBu/A23187 .
Biological Activity of GM-CSF in NK Cell Supernatants.
￿
The biological activity of
GM-CSF in 18-h cell-free supernatant fluids of purified (10-d culture)NK cells cul-
tured in medium, rIL-2, EA7S, or EA7S and rIL-2, was measured by its ability
to support proliferation of the TALL-101 cell line. Fig. 6 shows results of experi-
ments performed on supernatant fluids from NK cells of two different donors (out
of six analyzed) . Supernatant fluids from unstimulated NK cells did not support
TALL-101 cell proliferation . Supernatant fluids from NK cells stimulated with ei-
FIGURE 4 .
￿
Kinetics of cytokine mRNA accumula-
tion in cultured (A) and fresh (B)NK cells upon stim-
ulation with 3G8-Sepharose/rIL-2 . Total cytoplasmic
RNA was isolated from cultured or fresh NK cells
after the indicated time of stimulation with 3G8-
Sepharose/rIL-2 or after 2-h stimulation offresh NK
cells with PDBu/A23187 (right lane in B, indicated
with 2'). Northern blots were performed as described .
The experiments shown are representative of five
different experiments with cultured NK cells and
three with fresh NK cells.57 6
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FIGURE 5 .
￿
Immunoprecipitation ofGM-CSF from NK cell su-
pernatant fluid. Purified NK cells (10-d cultured cells) from two
donors were cultured for 18 h in the presence of [35S]methonine
in medium (lanes 1 and 2) or in medium containing 2 .5 x 10-7
M PDBu and 0 .2 Wg/ml A23187 (lanes 3 and 4) . GM-CSF was
precipitated from the supernatant fluids using biotin-labeled mAbs
to humanGM-CSF and streptavidin-agarose . The precipitates were
analyzed by 12.5% SDS-PAGE . Lane 5 : mol wt standard (x
10 -3 ) .
ther EA7S or rIL-2 induced low levels of proliferation only when used at high con-
centrations, whereas supernatant fluids from NK cells stimulated with both EA7S
and rIL-2 supported TALL-101 proliferation even when used at concentrations
<10-2 . Addition of a 1 :200 dilution of a polyclonal sheep anti-GM-CSF serum com-
pletely abolished proliferation induced by any supernatant fluid (Fig . 6 and data
not shown), whereas anti-IL-3 antiserum (1 :200) was ineffective (not shown) . On
the basis of titration curves with rGM-CSF (not shown), the proliferation-inducing
activity contained in the supernatant fluid from NK cells stimulated with 3G8-
Sepharose/rIL-2 was equivalent to that of 5-10 ng/ml rGM-CSF. As shown in Table
1, the NK cell supernatant fluids also contained TNF and IFN-'y . However, mAbs
neutralizingTNF orIFN-,y neither inhibited nor facilitated proliferation ofTALL-
101 cells induced by the supernatants (not shown) .
The supernatant fluids derived from the same two donors used for the above ex-
periments were also analyzed for CSF 1 biological activity by testing their ability
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FIGURE 6 .
￿
Ability of superna-
tant fluids from stimulatedNK
cells (A and B, two donors) to
induce proliferation of theGM-
CSF-dependent TALL-101 cell
line . Supernatant fluids were
added to the culture at the in-
dicated concentrations and the
assay was performed as de-
scribed in Materials and Meth-
ods . Supernatant fluids were
collected fromNK cellscultured
for 18 h in the presence of. " ,
medium ; " , rIL-2 100 U/ml;
" , EA7S; /, rIL-2 and EA7S;
Q, rIL-2 and EA7S, tested in
the presence ofsheep anti-GM -
CSF (1 :200) .to induce monocyte colonies from mouse bone marrow . Low but significant activity
was demonstrated in the supernatant fluids from NK cells stimulated with IL-2 and
EA7S in combination (data not shown) .
The ability oftheNK cell supernatant fluids to support CML blast proliferation,
an assay which is sensitive to GM-CSF, IL-3, and IFN-y, was also tested . Theability
of the supernatant fluids to induce proliferation in this assay paralleled that observed
with the TALL-101 cells . The supernatant fluids used in theCML blast assay (Fig .
7A) were the same used in the TALL-101 assay reported in Fig. 6B. Maximal prolifer-
ative activity (detectable at dilutions of the supernatants <10-2) was present in the
supernatant fluids from NK cells stimulated with 3G8-Sepharose/rIL-2 . CMLblast
proliferation induced by these supernatant fluids was partially inhibited by a poly-
TABLE I
IFN-y and TNF in Supernatant Fluids from Stimulated NK Cells
' NK cells (from 10-d cocultures ofPBMC and RPMI 8866 cells) were cultured
(5 x 106/ml, 18 h, 37°C) in the presence of the indicated stimuli ; the cell-
free supernatant fluids were collected and IFN-y andTNF measured by RIA .
t Supernatant fluids from NK cells of donor A and B are those shown in Fig .
6 A, and in Figs . 6 B and 7, respectively .
o
-2 _1 _a _3
Supernatant concentration, log
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Donor At
￿
Donor B
FIGURE 7 .
￿
Ability ofsuperna-
tant fluids from stimulatedNK
cells to induce proliferation of
CML blasts (A) and inhibition
by antibodies to cytokines (B) .
Supernatant fluids from NK
cells ofdonor B (in Table I and
Fig . 6 B), obtained as described
in Table I, were added to the
assay at the indicated concen-
trations . (A) Supernatant fluids
were from NK cells stimulated
with: " , medium;", rIL-2 100
U/ml ; A, EA7S; /, rIL-2 and
EA7S . (B) Supernatant fluids
from NK cells stimulated with
rIL-2 and EA7S were tested in
the presence of. /, medium ;
0, rabbit anti-IL-3 (1 :100) ; A,
anti-IFN-ymAb B133.3 (ascites
1 :100); O, sheep anti-GM-CSF
(1:200); 0, anti-IL-3 and anti-
GM-CSF ; 0, anti-GM-CSF
and anti-IFN-y .
Stimulus" IFN-y TNF IFN-y TNF
U/ml
Medium <0 .2 <0 .1 1 .3 0 .1
EA7S 10.9 1 .0 8 .1 0.4
rIL-2 1 .8 <0 .1 27 .6 0 .2
EA7S + HL-2 153 .7 42 .7 220 .4 36 .3578
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clonal sheep antiserum to GM-CSF and by an mAb to IFN-y, and completely
abrogated using the two antibodies together (Fig. 7 B). Rabbit anti-IL-3 did not
significantly affect proliferation when used either alone or in combination with anti-
GM-CSF (Fig. 7 B) or anti-IFN-y antibodies (not shown) . Identical results were
obtained when the neutralizing antibodies were added to the supernatant fluids from
NK cells stimulated with either EA7S or rIL-2 (not shown). Each of the three anti-
body preparations, at the dilutions used in this assay, completely and specifically
suppressed CML blast proliferation induced with quantities of the homologous
cytokines resulting in proliferation greater than that observed using the supernatant
fluids (not shown).
Supernatants from NK cells stimulated for 18 h with PDBu and A23187 were ex-
tensively dialyzed and tested in the CML blast proliferation assay. They induced
proliferation that was largely inhibited by anti-GM-CSF antibodies (Table II). The
remaining activity, unlike that observed with the supernatants from NK cells stimu-
lated with EA and rIL-2, was significantly inhibited by anti-IL-3 antibodies (Table II).
Discussion
We have analyzed the ability of purified homogeneous preparations of human NK
cells to produce CSF using optimal stimulation protocols. Our data clearly show
that, upon activation, NK cells produce GM-CSF, with similar or higher efficiency
than T cells. We have shown that GM-CSF mRNA is accumulated in appropriately
stimulated NK cells, and documented the presence of GM-CSF in the supernatant
fluids by precipitation of the protein and detection ofits biological activity. The pos-
sibility that contaminant T cells, and not NK cells, were the producers of GM-CSF
in our purified NK cell preparations was excluded by the observation that CD16
ligands, which stimulate GM-CSF production in NK cells, are inactive in T cells,
and that CD3 ligands, potent stimulators ofT cells, are inactive in our NK cell prepa-
rations. GM-CSF could then be the molecule responsible, at least in part, for the
BPA activity and for the activity of a factor(s) enhancing myeloid precursor colony
formation reportedly detected in NK cell supernatants (14, 15).
Transcripts of the IL-3 gene were detectable in NK cells, though at lower abun-
dance than those of GM-CSF, upon stimulation with phorbol diester and calcium
TABLE II
Ability of Supernatant Fluids from NK Cells Stimulated with
PDBu and A23187 to Induce Proliferation of CML Blasts
Supernatant fluids from NK cells (donors 1 and 2) stimulated for 18 h with PDBu and A23187
were extensively dialyzed against PBS and RPMI 1640 medium and assayed in the CML
blast proliferation assay at a 1:10 final dilution in the presence or absence of the indicated
antibodies. Sheep anti-GM-CSF was used at 1 :200 final dilution, rabbit anti-IL-3 at 1 :100.
Antibodies None
[3H]TdR uptake with
NK cells, donor
supernatant fluids:"
1 NK cells, donor 2
cpm
None 614 5,515 8,461
Anti-GM-CSF 595 2,772 4,174
Anti-GM-CSF + anti-IL-3 584 983 2,123CUTURI ET AL .
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ionophore . Whereas CD16 ligands/rIL-2 might also induce IL-3 gene expression
but to undetectable levels, this possibility seems unlikely because we detected no
IL-3 transcripts in CD16 ligands/rIL-2-stimulated NK cells even using poly(A)+
RNA. Alternatively or concomitantly, accessory cells, absent in ourNK cell prepa-
rations, maybe required for IL-3 production byNK cells, and such a requirement
mightbe bypassed usingphorbol ester and calcium ionophore for stimulation . Anti-
body inhibition studies in the CML blast proliferation assay show that NK cells
stimulated by PDBu/A23187 but not by CD16 ligands/rIL-2 produce biologically
active IL-3 . Aquantitative measurement of IL-3 in the supernatant fluids is presently
difficultbecause ofthepresence, in thesame supernatant fluids, ofvarious lymphokines
active in theCML blast proliferation assay and their possible synergistic or antagonistic
interaction . Because IL-3 transcripts are present at higher abundance in NK cells
than in comparably stimulatedTcells, NK cellsmight be oneof the major producers
ofhuman IL-3 . IL-3 produced byNK cellscould account, in addition to GM-CSF,
for at least some of theBPA activity detected in NK cell supernatants (14, 15, 18)
and also for the megakaryocyte-CSF activity attributed to NK cells (19) .
CSFI transcripts were detected, also at much lowerabundance than thoseofGM-
CSF, inNK cells stimulated with CD161igands/rIL-2 but not inNK cells stimulated
with phorbol diester/rIL-2 . The observation that GM-CSF, CSF1, and IL-3 are
differentially inducedusing distinct, though both optimal, stimulation protocols sug-
geststhat the genesencoding these cytokines are independently regulated . Low levels
of CSF1 biological activity can be demonstrated in NK cell supernatant fluids .
Transcripts for G-CSF, IL-la, and IL-1/3 were not detectable in NK cells even
when poly(A)+ RNA from optimally stimulated NK cells was used . Although the
conditions and time of stimulation we used might not have been optimal fordetec-
tion of mRNA of these three cytokines, our results strongly suggest that they are
not products of NK cells . By contrast, Scala et al . (41) reported that human LGL
are potent producers of IL-1 . However, the cell preparations used in that study, al-
though carefully purified, were not homogeneous preparations ofNK cells, and it
is possible that a contaminant cell population was the source of IL-1 . Alternatively,
NK cells might produce molecules with IL-1 activity but that differ from IL-1a or
IL-1a .
The kinetics ofmRNA accumulation for GM-CSF (and CSF1) in NK cells is
slower than that for TNF and IFN-y, suggesting that NK cells, upon stimulation,
first secrete factorswith an inhibitory effect on hematopoiesis and subsequently stimula-
tory factors . Thus, if stimulated NK cells produce suppressor factors such as TNF
and, in some cases, IFN-y, before or simultaneously with CSF, it might have been
difficult in previous studies to identify CSF activity. We (35) have shown that, in
order to demonstrate in vitro the presence ofGM-CSF activity in supernatants from
activatedT cells, it is necessary to deplete them of lymphotoxin, TNF, and IFN-y,
all factors synergizing to inhibit growth of the colony types induced by GM-CSF .
Depending on the type of colonies analyzed, the suppressor or stimulator factors
might have dominated and this might also explain why, when BPA activity was de-
tected, it was often observed in the absence of aGM-CSF activity. The two biolog-
ical assays used here foranalysis ofCSFbiological activity arenot significantly affected
by TNF and/or IFN-y . Proliferation of TALL-101 cells is not affected by these two
factors and elimination ofTNF and IFN-y from NK cell supernatant fluids does580
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not lead to increased proliferation of these cells (results not shown). In the case of
CML blast proliferation, IFN-y itselfacts as a proliferation-inducing factor, although
not as efficiently as GM-CSF or IL-3 (31).
The results presented in this paper show that NK cells have the potential to both
suppress and enhance hematopoiesis through release ofdistinct cytokines. However,
it is difficult to extrapolate these in vitro results to the in vivo situation. Although
TNF and IFN-y have direct inhibitory effects on hematopoietic precursor cells, they
can induce CSF production from monocytes, fibroblasts, and endothelial cells (42,
43) and can therefore stimulate hematopoiesis indirectly.
The three major cytokines produced by NK cells (TNF, IFN-,y, and GM-CSF)
can all function as extremely powerful activators ofphagocytic cells i.e., neutrophils,
eosinophils, and monocyte/macrophages (44-46). NK cells are important effector
cells in nonadaptive resistance and, as such, play a role in the first line of defense
against virus infection and tumormetastasis. The ready release ofcytokines by NK
cells broadens the action of these cells in nonadaptive resistance by enabling recruit-
ment of the other relevant effector cells. Production of such cytokines by NK cells
may also be important during an immune response through the interaction of the
FcR(CD16) with immunocomplexed Igs and IL-2. IFN-y and GM-CSF production
by NK cells in response to immune complexes is a specific function of NK cells,
not shared with other cell types. This may represent the main in vivo function of
NK cells, and their effects on bone marrow hematopoiesis in physiological condi-
tions might be only secondary. A more significant role is probably played by NK
cells in the regulation of extramedullary hematopoiesis . In pathological conditions,
activation, proliferation, and changes in anatomical distribution of NK cells, in-
cluding their persistence or migration in the bone marrow, might bring NK cells
in contact with hematopoietic precursor cells, thereby mediating suppression or regu-
lation of hematopoiesis.
Summary
We have analyzed the ability of highly purified preparations of human NK cells
to produce CSF NK cells, purified by negative selection from 10-d cultures ofPBMC
incubated with irradiated B-lymphoblastoid cell lines, were stimulated with rIL-2,
FcR(CD16) ligands (particulate immune complexes or anti-CD16 antibodies bound
to Sepharose), a combination ofCD161igands and rIL-2, or the phorbol diester phorbol
dibutyrate (PDBu) together with the Cat` ionophore A23187. Both rIL-2 and CD16
ligands induce accumulation of GM-CSF mRNA in NK cells and the combined
effect ofthe two stimuli is synergistic. Maximal accumulation of GM-CSF mRNA
is observed after PDBu/A23187 stimulation. The participation ofcontaminant T cells
in the observed expression of the GM-CSF gene is excluded because CD16 ligands
do not stimulate T cells and CD3 ligands, powerful stimulators of T cells, are inac-
tive on NK cells. Accumulation of CSR1 mRNA is observed only in NK cells stimu-
lated with both CD16 ligands and rIL-2, whereas accumulation of IL-3 mRNA is
observed only in NK cells stimulated with PDBu/A23187 . Transcripts of the G-CSF,
IL-la, and IL-1/3 genes were never detected in NK cells in these experiments. The
kinetics of accumulation of GM-CSF and CSF-1 mRNA in NK cells stimulated with
CD161igands and rIL-2 peaked at 2-4 h and was slower than that ofTNF and IFN-
y mRNA, which peak at 1 h. GM-CSF was precipitated from the supernatant fluidsof NK cells stimulated with PDBu/A23187 and its biological activity was demon-
strated by the ability of the supernatants to sustain proliferation of the TALL-101
cell line or CML blasts . Biological activity of IL-3 and CSF1 was demonstrable
in supernatant fluids ofNK cells stimulated with PDBu/A23187 and CD161igands/rIL-
2, respectively .
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